구제역 백신 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global foot and mouth disease vaccines market size is expected to reach USD 7.09 Billion in 2034 from USD 3.37 Billion in 2025, growing at a CAGR of 8.62 during 2026-2034.This market is expanding steadily due to the increasing need to control and prevent outbreaks of foot and mouth disease in livestock. Vaccines play a critical role in maintaining animal health and ensuring food security. The growing demand for livestock products and the need to prevent economic losses are key factors driving market growth. Additionally, government initiatives and vaccination programs are supporting market expansion.

Growth drivers include advancements in vaccine development and the increasing focus on disease prevention. Veterinary healthcare providers are adopting advanced vaccines to improve effectiveness and coverage. The expansion of livestock farming and the increasing awareness of animal health are also contributing to market growth. Furthermore, international trade regulations are encouraging the use of vaccines to maintain disease-free status.

Looking ahead, the foot and mouth disease vaccines market is expected to witness continuous innovation and development. Companies are likely to focus on developing more effective and long-lasting vaccines. The integration of advanced technologies will further enhance vaccine production and distribution. As global demand for animal products continues to rise, the market is anticipated to grow steadily.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Animal

• Cattle
• Sheep and Goat
• Swine
• Others

By Vaccine

• Modified/Attenuated Live
• Inactivated (Killed)
• Other Vaccines

By Distribution Channel

• Veterinary Hospitals & Clinics
• Government Institutions
• Others

COMPANIES PROFILED

• Merck & Co. Inc., Biogenesis Bago, Zoetis Inc., Boehringer Ingelheim International GmbH, Indian Immunologicals Limited, Bayer AG, Hester Biosciences Limited, Inner Mongolia Biwei Antai Biotechnology Co. Ltd., Brilliant Bio Pharma Limited, Biovet Private Ltd.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL FOOT AND MOUTH DISEASE VACCINES MARKET: BY ANIMAL 2022-2034 (USD MN and Million Doses)

• 4.1. Market Analysis, Insights and Forecast Animal
• 4.2. Cattle Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.3. Sheep and Goat Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.4. Swine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 5. GLOBAL FOOT AND MOUTH DISEASE VACCINES MARKET: BY VACCINE 2022-2034 (USD MN and Million Doses)

• 5.1. Market Analysis, Insights and Forecast Vaccine
• 5.2. Modified/Attenuated Live Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 5.3. Inactivated (Killed) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 5.4. Other Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 6. GLOBAL FOOT AND MOUTH DISEASE VACCINES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN and Million Doses)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Veterinary Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.3. Government Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 7. GLOBAL FOOT AND MOUTH DISEASE VACCINES MARKET: BY REGION 2022-2034 (USD MN and Million Doses)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 7.2.1 By Animal
  • 7.2.2 By Vaccine
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 7.3.1 By Animal
  • 7.3.2 By Vaccine
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 7.4.1 By Animal
  • 7.4.2 By Vaccine
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 7.5.1 By Animal
  • 7.5.2 By Vaccine
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 7.6.1 By Animal
  • 7.6.2 By Vaccine
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL FOOT AND MOUTH DISEASE VACCINES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Merck & Co. Inc
  • 9.2.2 Biogenesis Bago
  • 9.2.3 Zoetis Inc
  • 9.2.4 Boehringer Ingelheim International GmbH
  • 9.2.5 Indian Immunologicals Limited
  • 9.2.6 Bayer AG
  • 9.2.7 Hester Biosciences Limited
  • 9.2.8 Inner Mongolia Biwei Antai Biotechnology Co. Ltd
  • 9.2.9 Brilliant Bio Pharma Limited
  • 9.2.10 Biovet Private Ltd